{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:18:16Z","timestamp":1763018296591,"version":"3.37.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008741","name":"European League Against Rheumatism","doi-asserted-by":"publisher","award":["EPI025"],"award-info":[{"award-number":["EPI025"]}],"id":[{"id":"10.13039\/501100008741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1136\/annrheumdis-2020-218697","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T22:29:28Z","timestamp":1604701768000},"page":"518-526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0173-0668","authenticated-orcid":false,"given":"Christian","family":"Dejaco","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1105-5640","authenticated-orcid":false,"given":"Alessia","family":"Alunno","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0128-8451","authenticated-orcid":false,"given":"Johannes WJ","family":"Bijlsma","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0682-9533","authenticated-orcid":false,"given":"Annelies","family":"Boonen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4002-1861","authenticated-orcid":false,"given":"Bernard","family":"Combe","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1210-4347","authenticated-orcid":false,"given":"Axel","family":"Finckh","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-7972","authenticated-orcid":false,"given":"Pedro M","family":"Machado","sequence":"additional","affiliation":[]},{"given":"Ivan","family":"Padjen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3414-1667","authenticated-orcid":false,"given":"Francisca","family":"Sivera","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3073-7284","authenticated-orcid":false,"given":"Tanja A","family":"Stamm","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2534-550X","authenticated-orcid":false,"given":"Frank","family":"Buttgereit","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2020-218697_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106137","article-title":"A review of the 2019 novel coronavirus (COVID-19) based on current evidence","volume":"56","author":"Wang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1136\/annrheumdis-2020-218697_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30227-9","article-title":"Estimation of COVID-19 outbreak size in Italy","volume":"20","author":"Tuite","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib3","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(20)30627-9","article-title":"COVID-19 and Italy: what next?","volume":"395","author":"Remuzzi","year":"2020","journal-title":"The Lancet"},{"key":"10.1136\/annrheumdis-2020-218697_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"Cytokine storm in COVID-19 and treatment","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"key":"10.1136\/annrheumdis-2020-218697_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2020-218697_bib7","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1136\/annrheumdis-2020-218697_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","article-title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international Task force","volume":"75","author":"Smolen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib9","first-page":"948","article-title":"Update of the EULAR recommendations for the management of early arthritis","volume":"2017","author":"Combe","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib10","doi-asserted-by":"crossref","first-page":"000057","DOI":"10.1136\/rmdopen-2015-000057","article-title":"Rheumatoid arthritis treatment: the earlier the better to prevent joint damage","volume":"1","author":"Monti","year":"2015","journal-title":"RMD Open"},{"key":"10.1136\/annrheumdis-2020-218697_bib11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/annrheumdis-2020-217877","article-title":"EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2","volume":"79","author":"Landew\u00e9","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-218022","article-title":"Telemedicine will not keep us apart in COVID-19 pandemic","volume":"80","author":"Perniola","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib13","article-title":"Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic","author":"Santos-Moreno","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib14","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2020-217717","article-title":"COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine","volume":"79","author":"Bozzalla Cassione","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib15","article-title":"Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak","author":"So","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-218008","article-title":"COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases","volume":"80","author":"L\u00f3pez-Medina","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib17","doi-asserted-by":"crossref","DOI":"10.2196\/14730","article-title":"Mobile health apps for self-management of rheumatic and musculoskeletal diseases: systematic literature review","volume":"7","author":"Najm","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.1136\/annrheumdis-2020-218697_bib18","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/acr.22894","article-title":"Rheumatology workforce planning in Western countries: a systematic literature review","volume":"68","author":"Dejaco","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1136\/annrheumdis-2020-218697_bib19","first-page":"617","article-title":"American College of rheumatology workforce study: supply and demand projections of adult rheumatology workforce (2015-2030)","volume":"2018","author":"Battafarano","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1136\/annrheumdis-2020-218697_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2020-217763","article-title":"Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases","volume":"79","author":"Pablos","year":"2020","journal-title":"Ann Rheum Dis"},{"author":"National Health Service","key":"10.1136\/annrheumdis-2020-218697_bib22"},{"author":"Robert Koch Institut","key":"10.1136\/annrheumdis-2020-218697_bib23"},{"author":"Swiss Federal Office of Public Health","key":"10.1136\/annrheumdis-2020-218697_bib24"},{"author":"European Centre for Disease Prevention and Control","key":"10.1136\/annrheumdis-2020-218697_bib25"},{"key":"10.1136\/annrheumdis-2020-218697_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.16118","article-title":"Between fear and courage: attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic","author":"Reuken","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1136\/annrheumdis-2020-218697_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/annrheumdis-2012-203158","article-title":"EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis","volume":"72","author":"Colebatch","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib28","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib29","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/rheumatology\/kez397","article-title":"The role of ultrasound and magnetic resonance imaging for treat to target in rheumatoid arthritis and psoriatic arthritis","volume":"58","author":"Mandl","year":"2019","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2020-218697_bib30","first-page":"1","article-title":"American College of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"2016","author":"Singh","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/annrheumdis-2020-218697_bib31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7861\/clinmed.2020-0129","article-title":"and COVID-19 - a potential game changer?","volume":"20","author":"Sturrock","year":"2020","journal-title":"Clin Med"},{"key":"10.1136\/annrheumdis-2020-218697_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1136\/annrheumdis-2020-218697_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101663","article-title":"Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study","volume":"34","author":"Gautret","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1136\/annrheumdis-2020-218697_bib34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2020-218697_bib35","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N Engl J Med Overseas Ed"},{"key":"10.1136\/annrheumdis-2020-218697_bib36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11481-020-09930-x","article-title":"Does adding of hydroxychloroquine to the standard care provide any benefit in reducing the mortality among COVID-19 patients?: a systematic review","volume":"15","author":"Patel","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1136\/annrheumdis-2020-218697_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0853-0","article-title":"Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus","volume":"26","author":"Jakhar","year":"2020","journal-title":"Nat Med"},{"key":"10.1136\/annrheumdis-2020-218697_bib38","article-title":"Efficacy of tocilizumab in COVID\u201019: a systematic review and meta\u2010analysis","volume":"33","author":"Aziz","year":"2020","journal-title":"J Med Virol"},{"author":"Roche","key":"10.1136\/annrheumdis-2020-218697_bib39"},{"key":"10.1136\/annrheumdis-2020-218697_bib40","first-page":"1","article-title":"COVID-19 and NSAIDs: a narrative review of knowns and unknowns","author":"Pergolizzi","year":"2020","journal-title":"Pain Ther"},{"key":"10.1136\/annrheumdis-2020-218697_bib41","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jcv.2004.07.006","article-title":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients","volume":"31","author":"Lee","year":"2004","journal-title":"J Clin Virol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724101938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724101938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2020-218697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:03:40Z","timestamp":1737349420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724101938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0003496724101938"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2020-218697","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2020-218697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 \u00a9 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}